fbpx
Connect with us

CBD CONDITIONS & TREATMENTS

CBD Treatment of Acne

Published

on

As we continue to document the variety of different conditions and ailments for which CBD may provide a uniquely effective treatment, we continue to see themes emerge that suggest a direction of analysis that may be useful for scientists and researchers as we move forward and continue to shift the paradigm in the medical sciences where this remarkable compound is concerned in the future.

Another example of this unique and remarkable trend is the potential for CBD to be an active agent and a valuable weapon in the battle against acne.

Understanding Acne

One of the most remarkably common ailments, acne affects 8 out of every 10 people between the ages of 18 and 30 years.

The crux of this condition deals with the overproduction of a substance known as sebum. Sebum is the oil that coats the scalp and face of most species in the class mammalia.

The purpose of this substance is to transport dead cells to the surface of the skin as a means of waterproofing and protecting the dermis. However, with individuals of the ages mentioned above, it is often the case that an excess of sebum is produced and ends up collecting within the pores, preventing bacterial exodus, clotting up the pathways, and resulting in infected pores.

However, it’s important to understand that there is a clear correlation between deficits in the effective functioning of the endocannabinoid system and the presence of the imbalances that manifest themselves in the form of acne.

As we have seen in the case of other conditions, a lack of proper functionality for the endocannabinoid system can result in regulatory imbalances that produce a variety of different health conditions. In this case, that imbalance results in an excess of the presence of sebum in a further excess in inflammation of the dermis.

CBD and Acne

As noted above, there is an important role in the process that results in manifest acne that is due primarily to imbalances caused by deficits in the functionality of the endocannabinoid system.

As we have discussed in numerous other pieces, CBD is an important element as an extra treatment tool in responding to conditions representing an implicit imbalance in the functionality of the endocannabinoid system.

Specifically, the production of sebum appears to be mediated by CB2 receptors located in follicle cells. As we understand it, it would appear that the activation of these receptors is correlated with the excess production of sebum.

According to data, CBD – known to be a negative modulator of the CB2 receptor – which can be applied to the skin in the form of a lotion or ingested, has been shown to block the excessive action of this receptor to a degree that can remove the excess overproduction of sebum.

In addition, as we have seen throughout our in-depth examination and documentation, CBD is widely understood to have important anti-inflammatory properties due to the widespread role of the endocannabinoid system in regulating the body’s inflammatory response mechanisms.

In other words, CBD can impact both the overproduction of sebum and the excessive inflammation of the skin, which represent the two principal causes of the undesirable elements of acne.

Continue Reading
Advertisement

CBD CONDITIONS & TREATMENTS

CannTrust Holdings Inc (NYSE:CTST) Penetrates Into The United States After Investing $20 Million

Published

on

CannTrust Holdings Inc (NYSE:CTST), a Canadian company that produces and sells medical and recreational marijuana has announced the expansion of its business into the United States.

The Canadian firm revealed that it signed a Letter of Intent through which it will start working with Elk Grove Farming Company, LLC to access more than 3,000 hemp production acres in California. The two companies struck a joint partnership that will allow CannTrust to secure a footing in the California market which is one of the biggest cannabis markets in the U.S.

“This agreement represents another bold move for CannTrust. Our U.S. operation is expected to deliver a significant increase in low-cost production capacity,” stated CannTrust CEO Peter Aceto.

CannTrust is financially ready to tap into the U.S market

The CannTrust CEO also noted that the company will take advantage of its experience in the formulation of standardized CBD products as part of its strategy to enter the U.S market. Mr. Aceto also revealed that his company’s successful equity offering provided enough financial muscle to fuel its ambitious expansion plans.

CannTrust aims to be among the leading and trusted suppliers of high-quality, standardized CBD formulations derived from hemp. The company believes that there will be an increasing demand for high-grade CBD formulations from international retailers. It therefore makes sense to invest in processes that will add value to the end product such as genetic studies and expert growing practices to achieve the highest safety and quality standards.

Elk Grove and CannTrust will each have 50% ownership in their joint operations. Elk Grove is an ideal partner for the endeavor because it has years of farming experience in a variety of products. Its focus includes products designed for crop protection, supply, and input. Its operations are distributed across California, which means that the groundwork has already been laid for the partnership. It will thus be easier for the CannTrust to penetrate into the California market.

Elk Grove executive Morgan Houchin stated that his company was excited about the partnership with CannTrust. He added that his firm’s experience in farming operations will be a great combination with CannTrust’s experience in creating class-leading formulations.

Continue Reading

CBD CONDITIONS & TREATMENTS

Rocky Mountain High Brands Inc (OTCMKTS:RMHB) Strikes Broker Deal With Carlin Group

Published

on

Lifestyle brand management firm Rocky Mountain High Brands Inc (OTCMKTS:RMHB) announced on Wednesday that it secured a broker deal with Carlin Group for its products in the retail space.

The broker agreement will allow Carlin to represent RMHB’s CBD-infused drinks through the HEMPd brand. It will also represent beverages infused with Hempseed extract under RMHB brands. The deal will also cover CBD-infused wellness products such as lotions, water-soluble solutions, capsules, gummies and tinctures as part of the HEMPd brand. Spirit Water will also be covered under the agreement.

The RMHB-Carlin broker deal covers multiple states. They include Missouri, Nebraska, Texas, South Dakota, North Dakota, Minnesota, Wisconsin, Illinois, Pennsylvania, Tennessee, Kentucky, Ohio, Indiana, and Michigan.

“We are very excited about the opportunity to have our entire product line represented by Carlin Group,” stated RMHB CEO Michael Welch.

The Carlin broker deal will boost RMHB’s exposure

Welch noted that the broker deal will strategically allow RMHB to leverage optimal exposure to mass marketers, grocery store chains, convenient stores, major retailers and other types of outlets. The company would not have managed to reach such a wide range of outlets cost-effectively without a broker deal.

The RMHB CEO also added that his company and Carlin will maintain a close collaboration so that they can facilitate retail availability of RMHB products. Welch also revealed that RMHB reviewed numerous other retail introduction options. This was before settling on Carlin which the company believes is the best-suited brand to rapidly get its products onto retail shelves.

Carlin Group’s Managing Director Albert Vergilio noted in a statement that his company was excited to host RMHB and the CBD-based products that are part of its HEMPd brand in Carlin’s new CBD division. He also added that it is part of investing in the future of CBD considering the fast-tracked popularity of CBD products, and the regulations that govern them.

Carlin’s sales team will undergo some training to get them acquainted with RMBH’s products. The sales team will then hold meetings with corporate customers as part of the retail rollout of the products. Sales that will be part of the broker deal are expected to kick off in Q3.

Continue Reading

CBD CONDITIONS & TREATMENTS

Wildflower Brands Inc (OTCMKTS:WLDFF) Establishes Footprint Across The US With PO For Hemp CBD Products From Dillard’s Department Stores And Eyes Markets In Texas And Florida

Published

on

Wildflower Brands Inc (OTCMKTS:WLDFF) has announced establishing a nationwide presence with a PO from Dillard’s Department store. The company has fulfilled the PO received from Dillard.

Hemp CBD products in 292 locations

Dillard’s department store will showcase the premium hemp CBD products of Wildflower in its 292 locations across the US. With its best practices and transparency, Wildflower is eyeing the key markets in Texas and Florida. The company will educate the customers in these regions about salable products. Wildflower has received subsequent orders from Dillard’s and is fulfilling the requirements.

Chief Executive Officer of Wildflower, William Maclean said the supply of CBD infused products to Dillard’s Department stores doubles the existing retail locations in the nation. The company aims to capitalize on its brand to become a household name. It will improve loyalty building because of the reputation and respect of Dillard’s as a retailer. Wildflower aims to provide health and wellness benefits of its CBD infused products to the customers in the US through Dillard’s.

Signs a deal with Highmark Interactive

Wildflower has signed a deal to use EQ – Brain Tracking, mobile software of Highmark Interactive, in the clinical research to study the functional neurological and cognitive effects of CBD. The company aims to get meaningful results and data that help to understand the functional and cognitive neurological properties of the cannabinoids.

William said the company would collect testimonials from the customers on its products that provide the health and wellness needs using plant-based solutions. The company will strive to improve the products, and the research helps it to reach that goal and growth with continued investments.

Acquires City Cannabis Corp

Wildflower has signed an LOI on April 3, 2019, to take over City Cannabis Corp. The company will issue its 60 million common shares for the takeover. The companies will complete the acquisition on receiving advice from corporate, tax, and securities law departments.

The cannabis retailer City Cannabis holds two licenses in the City of Vancouver to market cannabis. It is generating profits through operating dispensaries in Vancouver. The acquisition helps Wildflower to expand retail footprint using the expertise of City Cannabis.

Continue Reading
Advertisement
Advertisement
Advertisement






Trending Stories